drugset
drugset / Trial / NCT04145245

A Randomized Controlled Trial to Assess the Effect of L-carnitine in Patients With Diabetic Peripheral Neuropathy to Relief Pain and Symptom Improvement

NCT04145245 ↗

Phase 2 Unknown 104 enrolled Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
RandomizedParallel-groupDouble-blindTreatment

Summary

Diabetic Peripheral Neuropathy (DPN) is a common complication of diabetes mellitus. The prevalence rate is approaching towards a peak throughout the world including Bangladesh. The current intervention used in peripheral neuropathy does not bring satisfactory result. Recent trial shows that L-carnitine is effective and safe in DPN. So it is expected that L-carnitine may produce better effect in compared to other medicine used previously for alleviation of DPN.

Timeline

Start
2018-04-17
Primary completion
2019-12-30
Completion
2020-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject L-carnitine Other / unclassified 1500 mg Oral

Indications

No indication recorded.